<unk>  (E2/DRSP), sold under the brand name Angeliq, is a combination of estradiol (E2), an estrogen, and<unk>  (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used in menopausal hormone therapy, specifically the treatment of menopausal syndrome and osteoporosis, in postmenopausal women. It is taken by mouth and contains 0.5 to 1 mg E2 and 0.25 to 0.5 mg DRSP per tablet. The medication was approved in the United States in 2005. It is marketed widely throughout the world.
Estradiol/drospirenone
Estradiol/norethisterone acetate
Estradiol valerate/cyproterone acetate
Estradiol enantate/algestone acetophenide
Mestranol/norethisterone
Estradiol undecylate/norethisterone enanthate
Relugolix/estradiol/norethisterone acetate
Estradiol pivalate/progesterone